Procaine HCl (Gerovital H3): A weak, reversible, fully competitive inhibitor of monoamine oxidase
A specially stabilized form of procaine hydrochloride (Gerovital H3) has been shown to be a more potent inhibitor of monoamine oxidase than procaine HCl itself and a weaker inhibitor of this enzyme than iproniazid. This preparation was studied to determine its mode of interaction with monoamine oxidase using purified rat brain mitochondrial monoamine oxidase as the enzyme source. Reaction velocities were determined spectrophotometrically by quantitating the rate of appearance of 4-hydroxyquinoline from kynuramine. Dilutional studies comparing the mechanism of inhibition of monoamine oxidase produced by Gerovital H3 and by iproniazid demonstrated that Gerovital H3 was a reversible inhibitor of monoamine oxidase. Analysis of studies using LineweaverBurk and Dixon plots revealed that Gerovital H3 was a fully competitive inhibitor of monoamine oxidase. That Gerovital H3 is a weak, reversible, competitive inhibitor of monoamine oxidase may explain the absence of adverse reactions associated with the clinical use of Gerovital H3 as compared to the severe adverse reactions that have been associated with the use of irreversible monoamine oxidase inhibitors.—MacFarlane, M. D. Procaine HCI (Gerovital H3): A weak, reversible, fully competitive inhibitor of monoamine oxidase. Federation Proc. 34: 108–110, 1975.
KeywordsMonoamine Oxidase Percent Inhibition Irreversible Inhibitor Federation Proc Procaine Hydrochloride
Unable to display preview. Download preview PDF.
- 1.Aslan, A. Therapiewoche 7: 14, 1956.Google Scholar
- 4.Cohen, S. 20th Annual meeting of the Academy of Psychosomatic Medicine, 1973.Google Scholar
- 5.Davidson, A. N. Biochem. J. 67: 316, 1957.Google Scholar
- 8.Hrachovec, J. P. Federation Proc. 31: 604, 1972.Google Scholar
- 16.Robinson, D. S., J. M. Davis, A. Nies, R. W. Colborn, J. N. Davis, H. R. Bourne, W. E. Bonney, D. M. Shaw AND A. J. Coppen. Lancet I: 290, 1972.Google Scholar
- 18.Sakalis, G., D. OH, S. Gershon AND B. Shopsin. Current Therap. Res. 16: 59, 1974.Google Scholar
- 22.Wiessbach, H., T. E. Smith, J. W. Daly, B. Witkop AND S. Odenfriend. J. Biol. Chem. 235: 1160, 1960.Google Scholar